Sirolimus and Secondary Skin-Cancer Prevention in Kidney Transplantation
作者： Sylvie Euvrard , Emmanuel Morelon , Lionel Rostaing , Eric Goffin , Anabelle Brocard
关键词:
摘要: Switching from calcineurin inhibitors to sirolimus had an antitumoral effect among kidney-transplant recipients with previous squamous-cell carcinoma. These observations may have implications concerning immunosuppressive treatment of patients cutaneous carcinomas. (Funded by Hospices Civils de Lyon and others; TUMORAPA ClinicalTrials.gov number, NCT00133887.).
uzh.ch
ulb.ac.be
sci-hub.se 参考文章(40)
Arnold Sanderson, IgG-Subklassen der menschlichen Immunglobuline Immunology. ,vol. 31, pp. 675- ,(1976)
Günther F.L. Hofbauer, Jan Nico Bouwes Bavinck, Sylvie Euvrard, Organ transplantation and skin cancer: basic problems and new perspectives Experimental Dermatology. ,vol. 19, pp. 473- 482 ,(2010) , 10.1111/J.1600-0625.2010.01086.X
Minoru Hojo, Takashi Morimoto, Mary Maluccio, Tomohiko Asano, Kengo Morimoto, Milagros Lagman, Toshikazu Shimbo, Manikkam Suthanthiran, Cyclosporine induces cancer progression by a cell-autonomous mechanism Nature. ,vol. 397, pp. 530- 534 ,(1999) , 10.1038/17401
R. Salgo, J. Gossmann, H. Schöfer, H. G. Kachel, J. Kuck, H. Geiger, R. Kaufmann, E. H. Scheuermann, Switch to a Sirolimus‐Based Immunosuppression in Long‐Term Renal Transplant Recipients: Reduced Rate of (Pre‐)Malignancies and Nonmelanoma Skin Cancer in a Prospective, Randomized, Assessor‐Blinded, Controlled Clinical Trial American Journal of Transplantation. ,vol. 10, pp. 1385- 1393 ,(2010) , 10.1111/J.1600-6143.2009.02997.X
CM Proby, CA Harwood, RE Neale, AC Green, S Euvrard, L Naldi, Gianpaolo Tessari, MCW Feltkamp, MNC De Koning, WGV Quint, T Waterboer, M Pawlita, S Weissenborn, U Wieland, H Pfister, E Stockfleth, I Nindl, D Abeni, J Ter Schegget, JN Bouwes Bavinck, None, A case-control study of betapapillomavirus infection and cutaneous squamous cell carcinoma in organ transplant recipients. American Journal of Transplantation. ,vol. 11, pp. 1498- 1508 ,(2011) , 10.1111/J.1600-6143.2011.03589.X
D. C. Brennan, C. Legendre, D. Patel, K. Mange, A. Wiland, K. McCague, F. S. Shihab, Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: pooled analysis of three clinical trials. American Journal of Transplantation. ,vol. 11, pp. 2453- 2462 ,(2011) , 10.1111/J.1600-6143.2011.03674.X
D. Cattaneo, S. Merlini, S. Zenoni, S. Baldelli, E. Gotti, G. Remuzzi, N. Perico, Influence of Co‐Medication with Sirolimus or Cyclosporine on Mycophenolic Acid Pharmacokinetics in Kidney Transplantation American Journal of Transplantation. ,vol. 5, pp. 2937- 2944 ,(2005) , 10.1111/J.1600-6143.2005.01107.X
S. B. Campbell, R. Walker, S. See Tai, Q. Jiang, G. R. Russ, Randomized Controlled Trial of Sirolimus for Renal Transplant Recipients at High Risk for Nonmelanoma Skin Cancer American Journal of Transplantation. ,vol. 12, pp. 1146- 1156 ,(2012) , 10.1111/J.1600-6143.2012.04004.X
Xunwei Wu, Bach-Cuc Nguyen, Piotr Dziunycz, Sungeun Chang, Yang Brooks, Karine Lefort, Günther F. L. Hofbauer, G. Paolo Dotto, Opposing roles for calcineurin and ATF3 in squamous skin cancer Nature. ,vol. 465, pp. 368- 372 ,(2010) , 10.1038/NATURE08996
Francesco P Schena, Michael D Pascoe, Josefina Alberu, Maria del Carmen Rial, Rainer Oberbauer, Daniel C Brennan, Josep M Campistol, Lorraine Racusen, Martin S Polinsky, Robert Goldberg-Alberts, Huihua Li, Joseph Scarola, John F Neylan, Sirolimus CONVERT Trial Study Group, Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial. Transplantation. ,vol. 87, pp. 233- 242 ,(2009) , 10.1097/TP.0B013E3181927A41